Better Than GLPs? Exclusive Interview with Neuroscientist about Weight Loss Treatments

It is no secret that the US is experiencing an obesity crisis and many are embracing GLP-1 agonist weight loss drugs. Racial and ethnic minorities on the other hand, and people with low incomes or living in rural areas, still struggle with obesity/type 2 diabetes mellitus and prediabetes, especially when they live in under-resourced and medically underserved communities.